514 related articles for article (PubMed ID: 29726916)
1. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
Samuels JB; Garcia MA
Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
[TBL] [Abstract][Full Text] [Related]
2. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
[TBL] [Abstract][Full Text] [Related]
3. Fractional CO
Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
5. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
[TBL] [Abstract][Full Text] [Related]
6. Fractional CO2 Laser for Vulvovaginal Atrophy.
Lekskulchai O; Mairaing K; Vinayanuvattikhun N
J Med Assoc Thai; 2016 Jul; 99 Supopl 4():S54-8. PubMed ID: 29916683
[TBL] [Abstract][Full Text] [Related]
7. Fractional Co
Alexiades MR
Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
9. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
10. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
12. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
13. Microablative Fractional CO
Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
15. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy.
Salvatore S; Athanasiou S; Candiani M
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):504-8. PubMed ID: 26536212
[TBL] [Abstract][Full Text] [Related]
16. Safety evaluation of fractional CO
Di Donato V; D'Oria O; Scudo M; Prata G; Fischetti M; Lecce F; Schiavi MC; Giannini A; Muzii L; Battaglia F; Monti M; Benedetti Panici P
Maturitas; 2020 May; 135():34-39. PubMed ID: 32252962
[TBL] [Abstract][Full Text] [Related]
17. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
[TBL] [Abstract][Full Text] [Related]
18. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study.
Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM;
J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
[TBL] [Abstract][Full Text] [Related]
20. Long-term reliability of fractioned CO
Pieralli A; Bianchi C; Longinotti M; Corioni S; Auzzi N; Becorpi A; Fallani MG; Cariti G; Petraglia F
Arch Gynecol Obstet; 2017 Nov; 296(5):973-978. PubMed ID: 28866727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
